IRIS UniCatt

Pompili, Maurizio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 13.683
AS - Asia 10.977
EU - Europa 10.754
SA - Sud America 2.013
AF - Africa 231
Continente sconosciuto - Info sul continente non disponibili 30
OC - Oceania 22
Totale 37.710
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 13.301
SG - Singapore 5.039
DE - Germania 3.595
CN - Cina 2.616
SE - Svezia 1.727
BR - Brasile 1.599
IT - Italia 1.334
VN - Vietnam 980
FR - Francia 899
UA - Ucraina 740
IE - Irlanda 521
GB - Regno Unito 493
FI - Finlandia 388
ID - Indonesia 348
IN - India 343
JP - Giappone 334
RU - Federazione Russa 258
PL - Polonia 243
TR - Turchia 240
BD - Bangladesh 237
HK - Hong Kong 204
CA - Canada 185
AR - Argentina 165
IQ - Iraq 116
MX - Messico 104
NL - Olanda 104
BE - Belgio 74
EC - Ecuador 70
ES - Italia 68
KR - Corea 67
AT - Austria 63
ZA - Sudafrica 58
SA - Arabia Saudita 55
PK - Pakistan 44
IR - Iran 42
PH - Filippine 42
CZ - Repubblica Ceca 39
VE - Venezuela 37
CI - Costa d'Avorio 36
MA - Marocco 34
CO - Colombia 32
AE - Emirati Arabi Uniti 30
CH - Svizzera 29
IL - Israele 29
LT - Lituania 29
PY - Paraguay 28
PE - Perù 27
UZ - Uzbekistan 27
EG - Egitto 26
RO - Romania 26
JO - Giordania 23
CL - Cile 21
EU - Europa 21
KE - Kenya 21
AU - Australia 19
UY - Uruguay 18
AZ - Azerbaigian 17
KG - Kirghizistan 16
NP - Nepal 16
AL - Albania 15
PT - Portogallo 15
BO - Bolivia 13
GR - Grecia 13
KZ - Kazakistan 13
MY - Malesia 13
PA - Panama 13
DZ - Algeria 12
TT - Trinidad e Tobago 12
TW - Taiwan 12
CR - Costa Rica 11
JM - Giamaica 11
BG - Bulgaria 10
HU - Ungheria 10
NI - Nicaragua 10
HN - Honduras 9
TN - Tunisia 9
BH - Bahrain 8
ET - Etiopia 8
GE - Georgia 8
MD - Moldavia 8
TH - Thailandia 8
BZ - Belize 7
DK - Danimarca 7
BA - Bosnia-Erzegovina 6
LB - Libano 6
LK - Sri Lanka 6
LV - Lettonia 6
OM - Oman 6
SY - Repubblica araba siriana 6
CY - Cipro 5
DO - Repubblica Dominicana 5
HR - Croazia 5
KH - Cambogia 5
SK - Slovacchia (Repubblica Slovacca) 5
TZ - Tanzania 5
A2 - ???statistics.table.value.countryCode.A2??? 4
BY - Bielorussia 4
CG - Congo 4
KW - Kuwait 4
NO - Norvegia 4
Totale 37.638
Salva come PNG Salva come JPEG
Città #
Singapore 2.824
Chandler 1.553
Ashburn 1.516
San Jose 1.347
Dublin 512
New York 510
Dallas 449
Beijing 441
Jacksonville 422
Los Angeles 351
Ho Chi Minh City 337
San Mateo 328
Nanjing 307
Jakarta 303
Tokyo 303
Lauterbourg 299
Hefei 267
Rome 245
Ann Arbor 234
Hanoi 228
Boston 222
Milan 220
The Dalles 215
Wilmington 211
Nürnberg 207
Munich 194
Frankfurt am Main 180
Princeton 176
Warsaw 174
Hong Kong 171
Chicago 161
Dearborn 158
Moscow 158
Izmir 155
Helsinki 148
São Paulo 148
Marseille 140
Cattolica 136
Houston 135
Woodbridge 123
Boardman 121
Nanchang 108
Seattle 108
Santa Clara 105
St Louis 103
Council Bluffs 97
Buffalo 93
Redwood City 84
Bremen 83
Fairfield 83
Kent 83
Paris 82
Brussels 72
Zhengzhou 68
Shenyang 67
Turku 67
London 64
Lancaster 63
Denver 58
Orem 58
Seoul 58
Kunming 57
Lawrence 56
Tianjin 56
Guangzhou 55
Nuremberg 55
Rio de Janeiro 54
Hebei 53
Hangzhou 52
Brooklyn 51
Montreal 51
Atlanta 50
Changsha 50
Da Nang 50
Toronto 49
Norwalk 48
Augusta 47
Hyderabad 47
Baghdad 46
Shanghai 46
Amsterdam 45
University Park 42
Haiphong 41
Pune 41
Stockholm 41
Mountain View 40
Redmond 40
Chennai 39
Dhaka 38
Phoenix 38
Vienna 38
Kraków 37
Mexico City 37
San Francisco 37
Abidjan 36
Belo Horizonte 36
Poplar 36
Tukwila 35
Jiaxing 32
Jinan 32
Totale 19.667
Salva come PNG Salva come JPEG
Nome #
Differentiating hepatocellular carcinoma from dysplastic nodules at gadobenate dimeglumine-enhanced hepatobiliary-phase magnetic resonance imaging 456
Posttransplant lymphoproliferative disorders after liver transplantation: analysis of early and late cases in a 255 patient series 354
Chemotherapy for Hepatocellular Carcinoma: Current Evidence and Future Perspectives. 303
A phase II study of sunitinib in advanced hepatocellular carcinoma 278
Enhancement patterns of intrahepatic mass-forming cholangiocarcinoma at multiphasic computed tomography and magnetic resonance imaging and correlation with clinicopathologic features 252
Single-step multimodal locoregional treatment for unresectable hepatocellular carcinoma: balloon-occluded percutaneous radiofrequency thermal ablation (BO-RFA) plus transcatheter arterial chemoembolization (TACE) 247
HepPar1-Positive Circulating Microparticles Are Increased in Subjects with Hepatocellular Carcinoma and Predict Early Recurrence after Liver Resection 240
Prevalence, characteristics and severity of non-alcoholic fatty liver disease in patients with chronic plaque psoriasis 239
Long term effectiveness of resection and radiofrequency ablation for single hepatocellular carcinoma <= 3 cm. Results of a multicenter Italian survey. 238
Complete Metabolic Response with Recanalization of Portal Vein Tumor Thrombosis after Sunitinib in a Patient with Advanced Hepatocellular Carcinoma 236
Prospective study of hepatitis B virus reactivation in patients with hematological malignancies 235
A machine-learning parsimonious multivariable predictive model of mortality risk in patients with Covid-19 234
Severe veno-occlusive disease after autologous peripheral blood stem cell transplantation for high-grade non-Hodgkin lymphoma: report of a successfully managed case and a literature review of veno-occlusive disease. 214
Role of diffusion-weighted imaging, apparent diffusion coefficient and correlation with hepatobiliary phase findings in the differentiation of hepatocellular carcinoma from dysplastic nodules in cirrhotic liver 213
Single-step multimodal locoregional treatment for unresectable hepatocellular carcinoma: balloon-occluded percutaneous radiofrequency thermal ablation (BO-RFA) plus transcatheter arterial chemoembolization (TACE) 206
Ethanol injection is highly effective for hepatocellular carcinoma smaller than 2 cm 203
TACE with degradable starch microspheres (DSM-TACE) as second-line treatment in HCC patients dismissing or ineligible for sorafenib 202
Non-alcoholic fatty liver disease is associated with high prevalence of gastro-oesophageal reflux symptoms 201
Non-alcoholic fatty liver disease is associated with high prevalence of gastro-oesophageal reflux symptoms 201
Botulinum toxin A versus B in sialorrhea: A prospective, randomized, double-blind, crossover pilot study in patients with amyotrophic lateral sclerosis or Parkinson's disease. 195
recurrent acute hepatitis associated with use of cetrizine 195
Accurate liquid biopsy for the diagnosis of non-alcoholic steatohepatitis and liver fibrosis 193
Effect of rifaximin on gut microbiota composition in advanced liver disease and its complications 191
Liver transplantation in patients with alcoholic liver disease: A retrospective study 191
Thrombotic risk factors in patients with liver cirrhosis: correlation with MELD scoring system and portal vein thrombosis development 190
Early prediction of response to sorafenib in patients with advanced hepatocellular carcinoma: the role of dynamic contrast enhanced ultrasound 190
The Effect of CYP, GST, and SULT Polymorphisms and Their Interaction with Smoking on the Risk of Hepatocellular Carcinoma 184
Presence of portal vein thrombosis in liver cirrhosis is strongly associated with low levels of ADAMTS-13: a pilot study 184
Contrast-enhanced ultrasound assessment of arterial vascularization of small nodules arising in the cirrhotic liver 179
Affective temperaments and psychopathological dimensions of personality in bipolar and cyclothymic patients 178
Radiofrequency ablation plus drug-eluting beads transcatheter arterial chemoembolization for the treatment of single large hepatocellular carcinoma 178
Early prediction of response to Sorafenib in patients with advanced hepatocellular carcinoma: the role of dynamic contrast enhanced ultrasound 176
Hepatocellular carcinoma recurrence in patients with curative resection or ablation: impact of HCV eradication does not depend on the use of interferon 176
Contrast-enhanced ultrasound in the short-term evaluation of hepatocellular carcinoma after locoregional treatment 176
A case of non-occlusive mesenteric ischemia and hepatic portal venous gas: not everyone knows that… 175
Hepatocellular carcinoma treated by conventional transarterial chemoembolization in field-practice: serum sodium predicts survival 173
Whole blood EBV-DNA predicts outcome in diffuse large B-cell lymphoma 172
L'insufficienza epatica: algoritmi diagnostici e trattamenti medici 171
Transarterial chemoembolization with degradable starch microspheres (DSM-TACE): an alternative option for advanced HCC patients? Preliminary results 170
A machine-learning parsimonious multivariable predictive model of mortality risk in patients with Covid-19 169
Long-term metformin treatment is able to reduce the prevalence of metabolic syndrome and its hepatic involvement in young hyperinsulinaemic overweight patients with polycystic ovarian syndrome 169
Therapeutic Approach to Post-Transplant Recurrence of Hepatocellular Carcinoma: Certainties and Open Issues 168
Treatment of recurrent genotype 4 hepatitis C after liver transplantation: early virological response is predictive of sustained virological response. An AISF RECOLT-C group study 165
Improved gut microbiota features after the resolution of SARS‑CoV‑2 infection 165
Liver involvement in hereditary hemorrhagic telangiectasia: can breath test unmask impaired hepatic first-pass effect? 164
Relationship between gastric localization of hepatitis C virus and mucosa-associated lymphoid tissue in Helicobacter pylori infection 164
Treatment of genotype-1 hepatitis C recurrence after liver transplant improves survival in both sustained responders and relapsers 164
Sarilumab use in severe SARS-CoV-2 pneumonia 164
Risk factors for intrahepatic recurrence of hepatocellular carcinoma in cirrhotic patients treated by percutaneous ethanol injection 162
Hug sign in intraprocedural cone-beam-CT to predict short-term response to combined treatment of hepatocellular carcinoma 161
[The treatment of hepatocellular carcinoma: an update] 161
An update on clinical applications of hepatospecific contrast media in magnetic resonance imaging of liver parenchyma 160
Contrast-enhanced gray-scale harmonic ultrasound in the efficacy assessment of ablation treatments for hepatocellular carcinoma 159
TACE with degradable starch microspheres (DSM-TACE) as second-line treatment in HCC patients dismissing or ineligible for sorafenib 159
Lung ultrasonography for early management of patients with respiratory symptoms during COVID-19 pandemic 159
Prevalence, characteristics and severity of non-alcoholic fatty liver disease in patients with chronic plaque psoriasis 158
HepatoCATT Study Group for the Multidisciplinary Management of HCC. Interventional oncology treatments for unresectable early stage HCC in patients with a high risk for intraprocedural bleeding: Is a single-step combined therapy safe and feasible? 158
Improvement of liver involvement in familial Mediterranean fever after introduction of canakinumab: a case report 158
Noninvasive Evaluation of Clinically Significant Portal Hypertension in Patients with Liver Cirrhosis: The Role of Contrast-Enhanced Ultrasound Perfusion Imaging and Elastography 156
Gastric wall thickness in normal and neoplastic subjects: a prospective study performed by abdominal ultrasound 156
Clinical features and comorbidity pattern of HCV infected migrants compared to native patients in care in Italy: A real-life evaluation of the PITER cohort 156
New signs and old applications of echo-color-Doppler should always be comapred to a gold-standard 155
The Role of Antibiotics in Gut Microbiota Modulation: The Eubiotic Effects of Rifaximin 155
Liver transplantation for hepatitis B virus patients: long-term results of three therapeutic approaches 153
revalence, characteristics and management of occult hepatitis B virus infection in patients with chronic lymphocytic leukemia: a single center experience. 152
Bariatric-metabolic surgery versus lifestyle intervention plus best medical care in non-alcoholic steatohepatitis (BRAVES): a multicentre, open-label, randomised trial 151
Enhancement patterns of intrahepatic mass-forming cholangiocarcinoma at multiphasic computed tomography and magnetic resonance imaging and correlation with clinicopathologic features 150
COVID-19-Related Social Isolation Predispose to Problematic Internet and Online Video Gaming Use in Italy 150
Correlation Between QElaXto Techniques and Supersonic Imagine for Liver Stiffness Quantification in Chronic Liver Disease 150
Severe Skin Burn at Needle Entry Point Complicating Radiofrequency Ablation for Hepatocellular Carcinoma 149
Project for interventional Oncology LArge-database in liveR Hepatocellular carcinoma - Preliminary CT-based radiomic analysis (POLAR Liver 1.1) 149
Ursodeoxycholic acid does not affect the clinical outcome of SARS-CoV-2 infection: A retrospective study of propensity score-matched cohorts 148
Portal vein tumor thrombosis revascularization during sorafenib treatment for hepatocellular carcinoma 148
Prognostic factors for survival in patients with early-intermediate hepatocellular carcinoma undergoing non-surgical therapy: comparison of Okuda, CLIP, and BCLC staging systems in a single Italian centre. 148
DNA ploidy pattern in human chronic liver diseases and hepatic nodular lesions. Flow cytometric analysis on echo-guided needle liver biopsy 148
Reverse time-dependent effect of alphafetoprotein and disease control on survival of patients with Barcelona Clinic Liver Cancer stage C hepatocellular carcinoma 148
Transradial versus Transfemoral Access for Hepatic Chemoembolization: Intrapatient Prospective Single-Center Study 148
Interventional Oncology and Immuno-Oncology: Current Challenges and Future Trends 147
Prevalence and predictors of non-alcoholic steatohepatitis in subjects with morbid obesity and with or without type 2 diabetes. 147
The role of antiplatelet therapies on incidence and mortality of hepatocellular carcinoma 146
Evaluation of the albumin-gamma-glutamyl transferase isoenzyme as a diagnostic marker of hepatocellular carcinoma-complicating liver cirrhosis. 146
Long-term metformin treatment is able to reduce the prevalence of metabolic syndrome and its hepatic involvement in young hyperinsulinaemic overweight patients with polycystic ovarian syndrome 144
Subclinical atherosclerosis is linked to small intestinal bacterial overgrowth via vitamin K2-dependent mechanisms 144
Skeletal Muscle Loss during Multikinase Inhibitors Therapy: Molecular Pathways, Clinical Implications, and Nutritional Challenges. 144
High prevalence of lower limb atherosclerosis is linked with the gut–liver axis in patients with primary biliary cholangitis 143
Doppler ultrasonographic evaluation of blood flow in the superior mesenteric artery in celiac patients and in healthy controls in fasting conditions and after saccharose ingestion 143
Dynamics of liver stiffness predicts complications in patients with HCV related cirrhosis treated with direct-acting antivirals 142
The nonstandard liver, a hidden resource that cannot be overlooked: implications for the identification of the best recipient. 141
Clinical suspicion of pancreatic neoplasm: does echo-guided fine-needle biopsy modify patient management? 141
Prevalence, characteristics and management of occult hepatitis B virus infection in patients with chronic lymphocytic leukemia: a single center experience 141
Impact of new DAA therapy on real clinical practice: A multicenter region-wide cohort study 141
Critical analysis of major and ancillary features of LI-RADS v2018 in the differentiation of small (< 2 cm) hepatocellular carcinoma from dysplastic nodules with gadobenate dimeglumine-enhanced magnetic resonance imaging 140
Botulinum toxin B ultrasound-guided injections for sialorrhea in amyotrophic lateral sclerosis and Parkinson's disease. 139
Single Hepatocellular Carcinoma Smaller than 2 cm: Are Ethanol Injection and Radiofrequency Ablation Equally Effective? 139
Liver Stiffness in Pediatric Patients with Fatty Liver Disease: Diagnostic Accuracy and Reproducibility of Shear-Wave Elastography 139
Lipohyperplasia of the ileocaecal valve as a cause of intestinal haemorrhage: an ultrasound Doppler study 138
Long-term metformin treatment is able to reduce the prevalence of metabolic syndrome and its hepatic involvement in young hyperinsulinaemic overweight patients with polycystic ovarian syndrome 138
Real-time contrast-enhanced ultrasound--a new simple tool for detection of peritoneal-pleural communications in hepatic hydrothorax 137
Acute hepatitis associated with use of paroxetine 137
Interventional oncology treatment for unresecable early stage HCC in patient with high risk for intraprocedural bleeding: is a single step combined therapy safe and feasible? 137
Totale 17.600
Salva come PNG Salva come JPEG
Categoria #
all - tutte 158.250
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 158.250
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202162 0 0 0 0 0 0 0 0 0 0 0 62
2021/20222.119 143 170 38 128 130 55 43 316 76 156 391 473
2022/20234.691 620 587 386 663 297 560 246 398 526 101 189 118
2023/20242.506 116 692 95 120 114 375 133 92 29 156 230 354
2024/20255.337 131 133 473 203 401 197 203 321 775 489 1.069 942
2025/202615.366 2.089 432 1.174 1.686 2.679 887 2.551 808 1.006 1.073 645 336
Totale 38.196